Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study

Table 4 SVR rates by the optimal overreported adherence threshold (25%), stratified by self-report levels

Self-report levels	< 25% Overreported adherence		≥ 25% Overreported adherence		p
Self-report levels	n/N	%	n/N	%	p
< 80%	14/20	70.0	3/6	50.0	.628^a
80-<85%	13/14	92.9	5/7	71.4	.247^a
85-<90%	15/18	83.3	9/9	100	.529^a
90-<95%	41/41	100	23/29	79.3	.004^a
95-<100%	92/93	98.9	49/53	92.5	.058^a
100%	146/149	98.0	48/54	88.9	.012^a
Overall sample	321/335	95.8	137/158	86.7	<.001^b

ISSN: 1471-2334